Will Sorrento Therapeutics Stock Continue To Make Fresh Lows?
- Tuesday, January 4, 2022, 7:10
- Market
- Add a comment
The stock of Sorrento Therapeutics, a clinical stage biopharma company that develops treatments for cancer and neurodegenerative diseases among others, has seen a decline of 16% over the last month, while it is down 17% over the last five trading days. Actually there were multiple positive…
About the Author
admin123 has written 23418 stories on this site.
